Meta-analysis of efficacy and safety of Tripterygium Glycosides Tablets combined with desloratadine in treatment of chronic urticarial.
10.19540/j.cnki.cjcmm.20181112.001
- Author:
Yan-Shuo SHI
1
;
Qi-Min WANG
1
;
Xue-Jia QIU
1
;
Guo-Xun PANG
1
Author Information
1. Department of Medicine,Hebei General Hospital Shijiazhuang 020051,China.
- Publication Type:Journal Article
- Keywords:
Meta-analysis;
Tripterygium Glycosides Tablets;
chronic urticaria;
clinical efficacy;
desloratadine
- MeSH:
Drug Therapy, Combination;
Drugs, Chinese Herbal;
therapeutic use;
Glycosides;
therapeutic use;
Humans;
Loratadine;
analogs & derivatives;
therapeutic use;
Quality of Life;
Randomized Controlled Trials as Topic;
Tablets;
Tripterygium;
chemistry;
Urticaria;
drug therapy
- From:
China Journal of Chinese Materia Medica
2019;44(16):3551-3557
- CountryChina
- Language:Chinese
-
Abstract:
To analyze the efficacy and safety of Tripterygium Glycosides Tablets combined with desloratadine as well as desloratadine alone in the treatment of chronic urticaria by Meta-analysis,in order to provide evidence-based reference for clinical treatment.PubMed,CBM,Wan Fang,VIP database and CNKI database were retrieved to collect randomized controlled trials( RCT) about Tripterygium Glycosides Tablets combined with desloratadine( test group) as well as desloratadine alone( control group) in the treatment of chronic urticaria. Meta-analysis was performed by using Rev Man 5. 3 software after data extraction and quality evaluation( a total of 15 RCTs were included,involving 1 411 patients). Meta-analysis showed that the total effective rate( RR = 1. 28,95%CI[1. 22,1. 35],P<0. 000 01) and the quality of life improvement rate( RR = 1. 49,95% CI[1. 33,1. 66],P< 0. 000 01) of the test group were better than those of the control group,and the recurrence rate( RR = 0. 29,95%CI[0. 21,0. 40],P<0. 000 01) was significantly lower than that of the control group,with statistically significant differences; there was no statistically significant difference in the incidence of adverse reactions( RR = 1. 02,95%CI[0. 68,1. 53],P = 0. 92) compared with the control group. Based on the included RCTs,the efficacy of Tripterygium Glycosides Tablets combined with desloratadine in the treatment of chronic urticaria were superior to those of desloratadine alone,with similarity in safety. However,due to the low quality of RCTs and the lack of large-scale multi-center studies,the results shall not be further verified by clinical trials.
